Understanding and improving HIV risk reporting in Arizona
Official title: Multilevel Determinants and Practice-Informed Solutions to Improve HIV Transmission Risk Reporting in Arizona
Funded at Arizona State University-Tempe Campus · NIH-11470974 · Data updated 2026-11-12
A short, patient-friendly look at how Arizona can better collect and use HIV transmission risk information to guide care and prevention.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project start | August 5, 2026 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $242,904 |
| NIH project number | 1R21AI203572-01 |
| Project ID | NIH-11470974 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not a clinical intervention; results will benefit public health strategies impacting people at risk for or living with HIV in Arizona.
✕Less likely to help
The project does not involve direct patient treatment or participation in a clinical trial, so there is no individual patient treatment plan.
What this research studies
This project focuses on the data and processes behind HIV reporting in Arizona to identify why transmission risk is often missing or unclear. Researchers will examine clinical and public health workflows, determine where gaps occur, and engage stakeholders to design practical improvements. The goal is to make surveillance data more complete so communities and clinics can target prevention and care more effectively. The study is exploratory and aims to translate findings into real-world changes in reporting practices.
Why it matters
Potential benefit: Improved HIV data could lead to better prevention efforts, more timely care, and more targeted resources for people living with HIV in Arizona.
How similar studies have gone: Previous work shows that improving data quality can enhance public health responses, though this project is exploring factors specific to Arizona’s reporting landscape.
Where this research is happening
-
Arizona State University-Tempe Campus
Scottsdale, United States Active
Researchers
- Principal investigator: Algarin, Angel B — Arizona State University-Tempe Campus
- Study coordinator: Algarin, Angel B
Related research
Other NIH-funded projects on the same topics.
-
Understanding how herpesviruses move and exit cells (focus on HSV-1 and PRV)
Scientists are studying how herpesviruses travel inside nerve cells and exit at the right spots, which could lead to better prevention and treatment of infections in people and animals.
-
Whole Protein Arrays to Find Antibodies Linked to Islet Autoimmunity in a Big Birth Cohort
This NIH grant aims to map antibodies against many microbes in children from the TEDDY study to understand what infections might be linked to the development of type 1 diabetes.
-
Climate heat and Alzheimer's risk in older adults
Heat exposure may influence brain health and dementia risk in older adults living in the United States.
-
Certified Cancer Registry Extraction with Proof-Certified Trust
A new AI-powered system helps cancer registries extract standardized data from medical records more accurately and with formal proofs to ensure trust.
-
Demystifying E. coli ecosystems with synthetic microbial communities
A project builds controlled, synthetic E. coli communities to uncover how different interactions shape colony behavior and health-related outcomes.
-
Aflatoxin exposure and child growth in Guatemala
A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.